2nd Quarter - Report
COVINGTON & BURLING LLP for ADAMIS PHARMACEUTICALS CORPORATION
Income
$80,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Legislation and rulemakings relating to opioid abuse and Naloxone access; H.R. 4007, the HEAL Act; H.R. 4531, the Support for Patients and Communities Reauthorization Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GARY HEIMBERG | — |
| GABRIEL NEVILLE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.